Brief: Intelgenx, Aquestive Therapeutics Enter Collaboration Agreement For Tadalafil

Intelgenx Technologies

08/05/2019 12:05

May 8 (Reuters) - Aquestive Therapeutics Inc  AQST.O :
    * INTELGENX AND AQUESTIVE THERAPEUTICS ENTER WORLDWIDE
COLLABORATION AGREEMENT FOR TADALAFIL
    * INTELGENX TECHNOLOGIES CORP - INTELGENX AND AQUESTIVE WILL
EACH
GRANT TO OTHER EXCLUSIVE WORLDWIDE LICENSES TO THEIR RESPECTIVE
INTELLECTUAL PROPERTY
    * INTELGENX TECHNOLOGIES CORP - DEAL FOR EXCLUSIVE WORLDWIDE
LICENSES PROPERTY RELATING TO TADALAFIL ORAL FILM FORMULATION
AND MANUFACTURING
    * INTELGENX TECHNOLOGIES CORP - INTELGENX WILL PAY AQUESTIVE
A
ROYALTY EQUAL TO 10% OF ALL PAYMENTS RECEIVED BY INTELGENX

Source text for Eikon:  ID:nGNX7L4RG0 
Further company coverage:  AQST.O 

 (Reuters.Briefs@thomsonreuters.com)